AZTherapies raising $20M, in Phase 3 trials for reformulated drugs that treat Alzheimer’s disease
AZTherapeutics approach is a two-pronged approach to treating Alzheimer's - slowing down plaque buildup and inhibiting the neuroinflammatory response.
aztherapeutics